Prostate Cancer Upgrading Reference Set
NCT02189486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 382
Last updated 2026-01-07
Summary
Research repository designed to establish prostate cancer upgrading reference set and development of a risk prediction tool. Repository will include clinical information and biologics on a cohort of 240 men, to predict presence of high grade cancer at time of prostatectomy (removal of prostate) among patients with a low grade cancer diagnosis at time of biopsy.
Conditions
Sponsors & Collaborators
-
Emory University
collaborator OTHER - collaborator OTHER
-
University of California, Irvine
collaborator OTHER - collaborator OTHER
-
The Cleveland Clinic
collaborator OTHER - collaborator OTHER
-
Fred Hutchinson Cancer Center
collaborator OTHER -
University of Miami
collaborator OTHER - collaborator OTHER
-
M.D. Anderson Cancer Center
collaborator OTHER -
Weill Medical College of Cornell University
collaborator OTHER -
Icahn School of Medicine at Mount Sinai
collaborator OTHER -
Eastern Virginia Medical School
collaborator OTHER -
National Cancer Institute (NCI)
collaborator NIH -
The University of Texas Health Science Center at San Antonio
lead OTHER
Principal Investigators
-
Ian M Thompson Jr, MD · University of Texas
Eligibility
- Min Age
- 35 Years
- Max Age
- 99 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2025-06-16
- Completion
- 2025-06-16
Countries
- United States
Study Locations
More Related Trials
-
Early Prostate Cancer: Predicting Treatment Response
NCT03770351 ·Status: UNKNOWN
-
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
NCT04404894 ·Status: ACTIVE_NOT_RECRUITING
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
NCT06398639 ·Status: RECRUITING ·Phase: NA
-
Multi-Institutional Registry for Prostate Cancer Radiosurgery
NCT01226004 ·Status: UNKNOWN
-
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
NCT02594202 ·Status: RECRUITING
-
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result
NCT01024959 ·Status: COMPLETED ·Phase: NA
-
Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer
NCT00769223 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Prostate Cancer and Patient-reported Outcomes Registry
NCT04694924 ·Status: RECRUITING
-
Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
NCT00991315 ·Status: TERMINATED
-
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
NCT05241236 ·Status: RECRUITING
-
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
NCT04995198 ·Status: RECRUITING
-
Precision-Based Genomics in Prostate Cancer
NCT04706663 ·Status: RECRUITING
-
Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers
NCT02844829 ·Status: UNKNOWN ·Phase: NA
-
MRI Screening in Men at High Risk of Developing Prostate Cancer
NCT05608694 ·Status: RECRUITING ·Phase: NA
-
Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients
NCT02209584 ·Status: COMPLETED
-
Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data
NCT00578409 ·Status: COMPLETED
-
Outcomes of Focal Ablation for Prostate Cancer
NCT05478694 ·Status: RECRUITING
-
Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS
NCT01766869 ·Status: WITHDRAWN
-
Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer
NCT02766543 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
NCT02588404 ·Status: WITHDRAWN
-
Micro-RNA Expression Profiles in High Risk Prostate Cancer
NCT01220427 ·Status: TERMINATED
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING
-
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
NCT05764005 ·Status: COMPLETED ·Phase: NA